Weekly influenza surveillance overview March 30 2012 - Week 12
The weekly influenza surveillance overview is a collection of timely and relevant information regarding influenza activity in Europe.
Facts about severe acute respiratory syndrome (SARS)
Severe acute respiratory syndrome (SARS) is a life-threatening respiratory disease caused by a recently identified coronavirus; the SARS-associated coronavirus (SARS-CoV). This is believed to be an animal virus that recently crossed the species barrier to infect humans.
Severe acute respiratory syndrome - Annual Epidemiological Report 2016 [2014 data]
Knowledge about the epidemiology and ecology of SARS coronavirus infection remains presently incomplete and the risk of re-emergence is unpredictable. The rapid spread of SARS worldwide showed the need to maintain surveillance despite the disease’s absence since 2003.
A network strategy to advance public health in Europe
Semenza, J.C., Apfel, F., Rose, T., Giesecke, J.
Developing pandemic preparedness in Europe in the 21st century: experience, evolution and next steps
Nicoll, A., Brown, C., Karcher, F., Penttinen, P., Hegermann-Lindencrone, M., Villanueva, S., Ciotti, M., Jean-Gilles, L., Rehmet, S., Nguyen-Van-Tam, J.S.
Rapid risk assessment, update: Severe respiratory disease associated with a novel coronavirus
CDC updated risk assessment concludes that in the absence of evidence of sustained person-to-person transmission outside of household settings, the current facts still point towards a hypothesis of a zoonotic or environmental source with occasional transmission to exposed humans. WHO does not advise any travel or trade restrictions at this point for KSA or Qatar.
European risk assessment guidance for infectious diseases transmitted on aircraft - the RAGIDA project
Rapid Risk Assessment: Severe respiratory disease associated with a novel coronavirus
New and noteworthy in this update: the retrospective identification of novel coronavirus in biological samples from two fatal cases in Jordan (April 2012) and the results of a joint ECDC/WHO survey which confirms that EU/EEA Member States have an adequate capacity to detect novel coronavirus through their network of national reference laboratories: 18 of 30 in EU/EEA countries are capable of confirming positive screened samples by either ORF1b RT-PCR or other target RT-PCR assays with sequence analysis or whole-genome sequence analysis.